Irving, TX, United States of America

Abhishek Goyanka

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Biological Innovation and Optimization Systems, LLC. Active years: 2019-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abhishek Goyanka. Retrieved from https://idiyas.com/inventor/abhishek-goyanka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Abhishek Goyanka: Pioneering Inventor from Irving, TX

Introduction: Abhishek Goyanka is a highly accomplished inventor based in Irving, TX, known for his groundbreaking innovations in various fields.

Latest Patents: Abhishek Goyanka holds several patents in the areas of technology and healthcare, with his most recent patent focusing on a revolutionary medical device for non-invasive treatment.

Career Highlights: With a career spanning over two decades, Abhishek Goyanka has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Abhishek Goyanka has collaborated with top research institutions, leading companies, and renowned universities to further advance his inventions and bring them to market successfully.

Conclusion: Abhishek Goyanka's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, making him a prominent figure in the world of patents and inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…